Table 2 Comparison of baseline characteristics between the PET negative and PET positive groups
PET negative (n = 110) | PET positive (n = 11) | p value | |
|---|---|---|---|
Age (years) | 69 (45–87) | 76 (58–83) | 0.401 |
Sex (male/female) | 68/42 | 5/6 | 0.341 |
Etiology (HCV/non-HCV) | 82/28 | 9/2 | 0.730 |
Fibrosis stage (F0–3/4) | 39/71 | 5/6 | 0.526 |
Child–Pugh class (A/B) | 87/23 | 10/1 | 0.691 |
Platelets (× 104/μL) | 9.0 (2.4–75.9) | 10.4 (2.9–21.2) | 0.351 |
ALT (IU/L) | 37 (10–171) | 45 (16–133) | 0.339 |
Hyaluronic acid (ng/mL) | 216.3 (23.2–1851.9) | 265.5 (85.0–884.9) | 0.438 |
Type IV collagen 7S (ng/mL) | 7.7 (3.0–18.0) | 7.3 (4.1–12.9) | 0.487 |
Tumor size (mm) | 18 (8–30) | 25 (15–30) | 0.001 |
Number of tumors (1/2/3) | 91/14/5 | 8/2/1 | 0.413 |
AFP (ng/mL) | 16.1 (1.8–1594.5) | 112.1 (3.1–1545.8) | 0.011 |
AFP-L3 (%) | 7.3 (0–72.5) | 28.9 (0–80.0) | 0.011 |
DCP (mAU/mL) | 58 (5–9489) | 177 (22–2615) | 0.008 |